Phase I Study of the Combination of Vandetanib and Dasatinib Administered During and After Radiation Therapy in Children With Diffuse Intrinsic Pontine Glioma.
Phase of Trial: Phase I
Latest Information Update: 08 Apr 2015
At a glance
- Drugs Dasatinib; Vandetanib
- Indications Glioma
- Focus Adverse reactions
- 03 Apr 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 26 Jun 2013 Planned end date changed from 1 Apr 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 13 Jun 2011 Planned end date changed from Jul 2013 to Apr 2013 as reported by ClinicalTrials.gov.